Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-09-19

Clinical Trial Update: Clopidogrel Prevention of Early Arteriovenous (AV) Fistula Thrombosis [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating clopidogrel for prevention of early arteriovenous fistula thrombosis in kidney failure patients undergoing hemodialysis has completed. …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CLOPIDOGREL (CLOPIDOGREL)

Snippet

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Conditions: Kidney Failure, Hemodialysis Fistula Thrombosis | Phase 3 | Status: COMPLETED